Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…educational initiatives to ensure safe prescribing practices of SGLT2 inhibitors in HF populations, particularly around perioperative and acute …
…own to be consistent across multiple hospital sites.Conclusions SGLT2 inhibitors are associated with a reduced risk of dementia and AD compared …
…lin and SGLT2 inhibitors, while DPP-4 inhibitors clustered with metformin ( figure 1). Heatmapping confirmed strong phenotype-specific en…
… long-term dual antithrombotic therapy (low-dose rivaroxaban or ticagrelor). This study compared cardiovascular outcomes of patients seen …
…duals at borderline or intermediate risk of ASCVD.16 Similarly, FIB-4 may serve an analogous role in nephrology by identifying patien…
…th diabetes (n=23), 14 (60.9%) are on insulin, 9 (39.1%) are on metformin, 7 (30.4%) are on SGLT2 inhibitors,5 (14.7%) are on sulfonylure…
…erences showed both regional similarities and differences, with SGLT2 inhibitors being the most preferred drug of choice universally. In contras…